Kindstar Globalgene Technology, Inc. (9960) Stock Statistics & Valuation Metrics

Kindstar Globalgene Technology, Inc. has a market cap or net worth of HK$984.05M. The enterprise value is -HK$560.72.

Kindstar Globalgene Technology, Inc. has 1,041,326,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kindstar Globalgene Technology, Inc.’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is -3.47%.

The current PE Ratio of Kindstar Globalgene Technology, Inc. is ―. Kindstar Globalgene Technology, Inc.’s PEG ratio is -6.54.

In the last 12 months, Kindstar Globalgene Technology, Inc. had revenue of 933.57M and earned -58.74M in profits. Earnings per share was -0.06.

In the last 12 months, operating cash flow was 182.33M and capital expenditures -43.94M, giving a free cash flow of 138.39M billion.

Kindstar Globalgene Technology, Inc. pays an annual dividend of HK$0.095, resulting in a dividend yield of 10.05%

Kindstar Globalgene Technology, Inc. upcoming earnings date is Mar 26, 2027, TBA (Confirmed).

Kindstar Globalgene Technology, Inc. as a current ratio of 2.81, with Debt / Equity ratio of 15.31%

In the past 12 months, Kindstar Globalgene Technology, Inc. has paid 14.76M in taxes.

Kindstar Globalgene Technology, Inc. EV to EBITDA ratio is -10.93, with an EV/FCF ratio of 23.98.

Kindstar Globalgene Technology, Inc. has HK$1.80B in cash and marketable securities with HK$394.97M in debt, giving a net cash position of HK$1.40B billion.

Gross margin is 45.55%, with operating margin of -11.89%, and net profit margin of -6.29%.

The average price target for Kindstar Globalgene Technology, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―